Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

EDAP Signs Distribution Agreements In Argentina, Brazil And Chile

EDAP TMS S.A. (EDAP), a developer and marketer of Ablatherm, has signed distribution agreements with partners in Argentina, Brazil and Chile to drive adoption of Ablatherm in the region as a therapeutic option for patients with prostate cancer. The company's partners will include Jorge Litter in Argentina, H. Strattner in Brazil and UMS in Chile.

Marc Oczachowski, EDAP’s chief executive officer, stated that the company strongly believes Jorge Litter in Argentina, H. Strattner in Brazil and UMS in Chile are the right partners to develop and build our presence in these countries as part of an ongoing effort to drive geographic expansion of our minimally-invasive HIFU option to patients with localized prostate cancer. Several clinical institutions have been showing strong interest in offering Ablatherm-HIFU to their patients and we are very enthusiastic to now provide them with a solution.